Fluorescence & Luminescence Spectroscopy Reagents Portfolio

Application Background

A bioanalytical chemistry laboratory developing quantitative LC-MS/MS methods for novel nociceptin/orphanin FQ peptide (NOP) receptor agonists required a reliable reference compound for method establishment and validation.

Due to the structural complexity and relatively low therapeutic dose range of MCOPPB-class compounds, accurate quantification in biological matrices (plasma and brain homogenates) was challenging. Key analytical issues included:

• Matrix suppression in electrospray ionization (ESI)
• Low ion stability under acidic mobile phases
• Difficulty in establishing reproducible calibration curves at low ng/mL levels

Analytical Solution

MCOPPB trihydrochloride hydrate was used as a primary analytical reference standard for:

• LC-MS/MS method development and optimization
• Calibration curve construction (matrix-matched standards)
• Retention time and fragmentation pattern identification
• Bioanalytical validation in plasma and brain tissue extracts

Optimized conditions included reversed-phase C18 separation with gradient elution and positive ESI detection mode, targeting characteristic product ions for multiple reaction monitoring (MRM).

Key Analytical Observations

• Stable ion transition signals were achieved under optimized MRM conditions
• Linear calibration curves were established across low-concentration range (sub-ng/mL to ng/mL level)
• Matrix effects reduced significantly after optimization of sample cleanup (protein precipitation + SPE)
• High reproducibility of retention time (RSD < 2%) across runs

Outcome

MCOPPB trihydrochloride hydrate enabled robust LC-MS/MS method development for NOP receptor ligand quantification in biological matrices, supporting pharmacokinetic and brain distribution studies with improved analytical sensitivity and reproducibility.

Application Background

A neurochemical analytical laboratory investigating monoamine oxidase B (MAO-B) inhibition kinetics required a validated analytical method to quantify:

• Substrate depletion (dopamine and related monoamines)
• Product formation (oxidized metabolites)
• Inhibitor concentration stability during incubation studies

Existing analytical methods suffered from limited separation efficiency between dopamine metabolites and endogenous matrix interferences in neuronal sample extracts.

Analytical Solution

Lazabemide hydrate was used as:

• Analytical reference standard for MAO-B inhibitor quantification
• Calibration standard in HPLC-UV and LC-MS/MS systems
• Stability reference compound in enzyme incubation assays

Analytical method optimization included:

• Reverse-phase HPLC separation using C18 column
• Gradient elution with aqueous buffer–organic solvent system
• UV detection coupled with confirmatory LC-MS analysis

Key Analytical Observations

• Clear chromatographic separation between Lazabemide and endogenous matrix components
• High linearity in calibration curves (R² > 0.995)
• Stable retention time across multiple analytical runs
• Reliable quantification in enzyme kinetic assays

Outcome

Lazabemide hydrate enabled the development of a robust analytical method for MAO-B inhibition studies, improving the accuracy of enzyme kinetics measurements and inhibitor concentration tracking in biological systems.

Application Background

A cancer metabolomics research laboratory studying folate-dependent nucleotide biosynthesis pathways required a chemically stable reference compound for LC-MS-based metabolic flux analysis.

The focus was on quantifying pathway disruption at the level of:

• Glycinamide ribonucleotide formyltransferase (GARFT) activity
• Purine intermediate accumulation
• Global nucleotide pool imbalance under antifolate stress

Analytical challenges included:

• Low abundance of intermediate metabolites
• Ion suppression in complex cellular extracts
• Difficulty in distinguishing pathway-specific inhibition effects

Analytical Solution

Lometrexol hydrate was used as:

• Reference inhibitor for pathway perturbation studies
• Calibration control compound in LC-MS metabolomics workflows
• Analytical benchmark for GARFT-mediated pathway suppression

LC-MS methodology included:

• High-resolution LC separation of polar nucleotide intermediates
• Negative ion mode ESI detection for metabolic profiling
• Targeted metabolite quantification using internal standard normalization

Key Analytical Observations

• Clear metabolic shift observed in purine biosynthesis intermediates
• Improved signal-to-noise ratio after optimized sample extraction
• Reproducible metabolic suppression patterns across replicates
• Accurate pathway-level quantification of GARFT inhibition effects

Outcome

Lometrexol hydrate enabled high-resolution LC-MS metabolic flux analysis of folate-dependent purine synthesis, supporting precise pathway-level quantification in cancer metabolism research.